ArticleChild and adolescent psychiatry and mental health2026
Comparative efficacy of pharmacological, adjunctive, and non-pharmacological interventions across behavioral domains in children and adolescents with autism spectrum disorder: a network meta-analysis.
Article in Child and adolescent psychiatry and mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Social Anxiety, Social Avoidance, Self-Esteem, and Loneliness: The Role of Class Type for Autistic Adolescents.Journal of autism and developmental disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo systematically compare the efficacy of pharmacological, adjunctive, and non-pharmacological interventions across multiple behavioral domains in children and adolescents with autism spectrum disorder (ASD), including irritability, hyperactivity, social withdrawal, stereotypic behavior, and inappropriate speech.
methodsFollowing the 2020 PRISMA guidelines, five databases were searched from inception to March 2026 for randomized controlled trials (RCTs). A frequentist network meta-analysis was conducted to estimate the comparative efficacy and ranking probabilities of different interventions across behavioral domains (PROSPERO: CRD420261368925).
resultsSixty-seven RCTs (N = 4,203) were included. For irritability, structured exercise ranked highest (SUCRA = 88.0%; SMD = - 1.48, 95% CI -2.24 to - 0.73), followed by risperidone plus adjunctive anti-inflammatory agents (SUCRA = 72.9%) and neuromodulatory agents (SUCRA = 67.8%). For hyperactivity, pharmacological interventions were most effective, with other antipsychotic/ADHD medications ranking highest (SUCRA = 95.1%; SMD = - 1.85, 95% CI -2.50 to - 1.20), followed by structured exercise (SUCRA = 76.1%). Similarly, for stereotypic behavior, pharmacological treatments dominated, with other antipsychotic/ADHD medications achieving the best performance (SUCRA = 92.0%; SMD = - 1.10, 95% CI -1.67 to - 0.52). In contrast, for social withdrawal, structured exercise emerged as the most effective intervention (SUCRA = 98.9%; SMD = - 1.28, 95% CI -1.96 to - 0.60), followed by risperidone plus neuromodulatory agents (SUCRA = 75.3%). For inappropriate speech, structured exercise (SUCRA = 80.1%) and probiotics plus oxytocin (SUCRA = 76.4%) demonstrated the highest rankings, with structured exercise showing a significant effect (SMD = - 0.80, 95% CI -1.40 to - 0.19).
conclusionThis study establishes a domain-specific treatment hierarchy for ASD, demonstrating that intervention effects vary substantially across behavioral domains. Pharmacological approaches are more effective for hyperactivity and stereotypic behaviors, whereas structured exercise shows superior benefits for irritability and social withdrawal. Combination strategies consistently rank highly across multiple domains, supporting the value of multimodal interventions. These findings underscore the importance of individualized, symptom-targeted, and mechanism-informed treatment strategies to optimize clinical outcomes in ASD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.